Age About 2 Years Or Younger (Age Factor)
Sotalol Hydrochloride Tablet
Product Images NDC 71335-2823
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sotalol Hydrochloride (NDC 71335-2823). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 (Figure2)
This excerpt provides P-values representing the recurrence-free survival rates between Oral Sotalol and Placebo at different dosages: 80 mg (P=0.325), 120 mg (P=0.018), and 160 mg (P=0.029). The data suggests that higher dosages of Oral Sotalol may lead to better recurrence-free survival rates compared to Placebo.*
Study 2 (Figure3)
Label (Lbl713352823)
This text provides information about a medication called Sotalol Hydrochloride. Each tablet contains 80 mg of the active ingredient. The usual dosage instructions are likely found in the package insert. It is recommended to store this medication at a temperature between 20°C to 25°C (68°F to 77°F) in a light-resistant container. The medication should be kept out of reach of children. The manufacturer is Bryant Ranch Prepack, Inc., and Oxford Pharmaceuticals LLC.*
Molecular Structure (Molecularstructure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
